Mon, Jul 14, 2014, 10:34 AM EDT - U.S. Markets close in 5 hrs 26 mins


% | $
Quotes you view appear here for quick access.

DexCom, Inc. (DXCM) Message Board

  • fly_my_brave_stallion fly_my_brave_stallion Aug 7, 2009 1:30 PM Flag

    Actual CGM Market...............

    Is MUCH, MUCH larger than it might first appear. Don't mistaken the early adopters.... largely comprised of intensively managed type I diabetics as the full market. They represent only a fraction of the evolving market.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I agree with you. Evidence is ample.

      a) inpatient glucose monitoring of diabetics in ICUs, step down units, and on most medical floors will become standard of care (and DXCM is poised with Edwards on this front).

      b) nearly all insulin-treated diabetics (type 1 AND type 2) will benefit greatly from CGM since nearly all of these patients manage their insulin dosing at home. CGM enables better choices by lay people in choosing their insulin doses, and will therefore become standard of care.

      Technology will make it cheaper and easier, but that should not affect margins due to economy of scale in both manufacturing and insurance eligibility determination.

36.63+0.02(+0.05%)10:34 AMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.